NEW YORK, May 21 – Agilent Technologies said Monday it had reached an agreement with Harvard University to jointly develop nanopore technology for the analysis of nucleic acids.

The terms of the multiyear deal were not disclosed, but Agilent did say the project could be extended.

The company said it would work with Harvard to develop technology that converts nucleotide sequences into electronic signatures, helping to speed up the sequencing process. Agilent did not say when it expected to release nanopore technology to market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.